1. Scrip

GSK Adds Another ADC In Second Deal With Hansoh

 
• By Jessica Merrill

Deal Snapshot: GSK is returning to its Chinese pharma partner Hansoh for a second ADC agreement, this time targeting B7-H3.

GSK licensed another ADC from Hansoh • Source: Shutterstock

Who: GSK./Hansoh Pharma

What: GSK will license a B7-H3 targeted antibody-drug conjugate (ADC), HS-20093, with potential in lung cancer and other solid tumors.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business